Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-28 @ 2:44 PM
Study NCT ID:
NCT02233504
Status:
COMPLETED
Last Update Posted:
2020-04-08
First Post:
2014-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study to Assess Hematologic Response in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndromes Undergoing Monotherapy With Exjade (Deferasirox)
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-04
First Submit QC Date:
None
Study First Post Date:
2014-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-07
Last Update Post Date:
2020-04-08
Last Update Post Date Type:
ACTUAL